Literature DB >> 19847890

Genome-wide scan identifies a copy number variable region at 3q26 that regulates PPM1L in APC mutation-negative familial colorectal cancer patients.

L F Thean1, C Loi, K S Ho, P K Koh, K W Eu, P Y Cheah.   

Abstract

Familial adenomatous polyposis (FAP) is an autosomal dominantly inherited form of colorectal cancer (CRC) caused by mutation in the adenomatous polyposis coli (APC) gene. However, APC mutations are not detected in 10-50% of FAP patients. We searched for a new cancer gene by performing genome-wide genotyping on members of an APC mutation-negative FAP variant family and ethnicity-matched healthy controls. No common copy number change was found in all affected members using the unaffected members and healthy controls as baseline. A 111 kb copy number variable (CNV) region at 3q26.1 was shown to have copy number loss in all eight polyps compared to matched lymphocytes of two affected members. A common region of loss in all polyps, which are precursors to CRC, is likely to harbor disease-causing gene in accordance to Knudsen's "two-hit" hypothesis. There is, however, no gene within the deleted region. A 2-Mb scan of the genomic region encompassing the deleted region identified PPM1L, coding for a novel serine-threonine phosphatase in the TGF-beta and BMP signaling pathways. Real-time PCR analyses indicate that the 3'UTR of PPM1L transcript was down-regulated more than two-folds in all six polyps and tumors compared to matched mucosa of the affected member. This down-regulation was not observed in APC mutation-positive FAP patients. Our results suggest that the CNV region at 3q26 harbors an element that regulates the expression of an upstream candidate tumor suppressor, PPM1L, thus providing a novel mechanism for colorectal tumorigenesis in APC mutation-negative familial CRC patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19847890     DOI: 10.1002/gcc.20724

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  20 in total

1.  Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer.

Authors:  Zhaoyu Li; Geetu Tuteja; Jonathan Schug; Klaus H Kaestner
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

2.  Germline DNA copy number variations as potential prognostic markers for non-muscle invasive bladder cancer progression.

Authors:  Yoshiaki Yamamoto; Yutaka Suehiro; Atomu Suzuki; Ryosuke Nawata; Yoshihisa Kawai; Ryo Inoue; Hiroshi Hirata; Hiroaki Matsumoto; Takahiro Yamasaki; Kohsuke Sasaki; Hideyasu Matsuyama
Journal:  Oncol Lett       Date:  2017-05-24       Impact factor: 2.967

3.  Genomics of Colorectal Cancer in African Americans.

Authors:  Hassan Brim; Hassan Ashktorab
Journal:  Next Gener Seq Appl       Date:  2016-09-21

4.  Mapping of genetic abnormalities of primary tumours from metastatic CRC by high-resolution SNP arrays.

Authors:  José María Sayagués; Celia Fontanillo; María del Mar Abad; María González-González; María Eugenia Sarasquete; Maria del Carmen Chillon; Eva Garcia; Oscar Bengoechea; Emilio Fonseca; Marcos Gonzalez-Diaz; Javier De las Rivas; Luís Muñoz-Bellvis; Alberto Orfao
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

Review 5.  Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers.

Authors:  H Wang; L Liang; J-Y Fang; J Xu
Journal:  Oncogene       Date:  2015-08-10       Impact factor: 9.867

6.  Genomic aberrations in an African American colorectal cancer cohort reveals a MSI-specific profile and chromosome X amplification in male patients.

Authors:  Hassan Brim; Edward Lee; Mones S Abu-Asab; Mohamed Chaouchi; Hadi Razjouyan; Hassanzadeh Namin; Ajay Goel; Alejandro A Schäffer; Hassan Ashktorab
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

7.  Germline DNA copy number variation in familial and early-onset breast cancer.

Authors:  Ana Cv Krepischi; Maria Isabel W Achatz; Erika Mm Santos; Silvia S Costa; Bianca Cg Lisboa; Helena Brentani; Tiago M Santos; Amanda Gonçalves; Amanda F Nóbrega; Peter L Pearson; Angela M Vianna-Morgante; Dirce M Carraro; Ricardo R Brentani; Carla Rosenberg
Journal:  Breast Cancer Res       Date:  2012-02-07       Impact factor: 6.466

8.  Germline copy number variations associated with breast cancer susceptibility in a Japanese population.

Authors:  Yutaka Suehiro; Takae Okada; Naoya Shikamoto; Yibo Zhan; Kohei Sakai; Naoko Okayama; Mitsuaki Nishioka; Tomoko Furuya; Atsunori Oga; Shigeto Kawauchi; Noriko Maeda; Michiko Tamesa; Yukiko Nagashima; Shigeru Yamamoto; Masaaki Oka; Yuji Hinoda; Kohsuke Sasaki
Journal:  Tumour Biol       Date:  2012-12-30

9.  Genome wide analysis of chromosomal alterations in oral squamous cell carcinomas revealed over expression of MGAM and ADAM9.

Authors:  Vui King Vincent-Chong; Arif Anwar; Lee Peng Karen-Ng; Sok Ching Cheong; Yi-Hsin Yang; Padmaja Jayaprasad Pradeep; Zainal Ariff Abdul Rahman; Siti Mazlipah Ismail; Zuraiza Mohamad Zaini; Narayanan Prepageran; Thomas George Kallarakkal; Anand Ramanathan; Nur Aaina Binti Mohd Mohayadi; Nurul Shielawati Binti Mohamed Rosli; Wan Mahadzir Wan Mustafa; Mannil Thomas Abraham; Keng Kiong Tay; Rosnah Binti Zain
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

10.  Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients.

Authors:  Bente A Talseth-Palmer; Elizabeth G Holliday; Tiffany-Jane Evans; Mark McEvoy; John Attia; Desma M Grice; Amy L Masson; Cliff Meldrum; Allan Spigelman; Rodney J Scott
Journal:  BMC Med Genomics       Date:  2013-03-26       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.